A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC
Clinical trial NCT05182944 · RECRUITING
Trial details
- NCT number
- NCT05182944
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-15
- Primary completion
- 2024-01-15
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.